|
Market Closed -
Nasdaq
16:00:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 16.42 USD | -6.17% |
|
-9.58% | - |
| 09-20 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
| Market Cap | 799M 714M 666M 605M 1.14B 77.28B 1.15B 8B 3.13B 39.3B 3B 2.93B 126B | P/E 2026 * |
-5.91x | P/E 2027 * | -7.84x |
|---|---|---|---|---|---|
| Enterprise Value | 420M 375M 350M 318M 599M 40.62B 603M 4.21B 1.64B 20.66B 1.58B 1.54B 66.41B | EV / Sales 2026 * |
900x | EV / Sales 2027 * | - |
| Free-Float |
91.15% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATTO | Delayed | |
CBOE
| ATTO | Real-time |
Last Transcript: Attovia Therapeutics, Inc.
| 1 day | -6.17% | ||
| 1 week | -9.58% | ||
| Current month | -4.20% | ||
| 1 month | -35.73% |
| 1 week | 16.33 |  | 18.5 |
| 1 month | 16.33 | | 28 |
| Current year | 16.15 | | 28 |
| 1 year | 16.15 | | 28 |
| 3 years | 16.15 | | 28 |
| 5 years | 16.15 | | 28 |
| 10 years | 16.15 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-12-15 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 2023-05-31 |
Tao Fu
CEO | Chief Executive Officer | 54 | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 2023-05-31 |
Tao Fu
BRD | Director/Board Member | 54 | 2023-03-31 |
James Topper
CHM | Chairman | 64 | 2023-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/6/26 | Goldman Sachs & Co. LLC (Private Banking)
| Conversion | Company | 25,562,737 | 59.4081% | |
| 8/6/26 | Conversion | 1,865,710 | 4.3359% | |||
| 8/6/26 | Deep Track Capital LP
| Conversion | Company | 20,138,956 | 46.8032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.17% | -9.58% | - | - | 799M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -1.16% | +23.36% | +79.34% | 58.81B | |
| +0.17% | -1.16% | +3.59% | +34.55% | 48.45B | |
| +0.50% | -1.77% | +331.24% | +702.20% | 42.84B | |
| -0.72% | -4.04% | +25.90% | +29.94% | 42.79B | |
| +0.34% | -0.34% | +5.66% | +109.35% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -0.50% | -3.37% | -9.42% | -14.35% | 24.05B | |
| Average | -0.61% | -0.59% | +52.65% | +123.79% | 39.51B | |
| Weighted average by Cap. | +0.47% | -0.55% | +55.51% | +130.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 467K 417K 389K 353K 665K 45.14M 670K 4.67M 1.83M 22.96M 1.75M 1.71M 73.81M | - |
| Net income | -83.44M -74.56M -69.56M -63.18M -119M -8.07B -120M -836M -327M -4.11B -313M -306M -13.2B | -107M -95.73M -89.32M -81.13M -153M -10.36B -154M -1.07B -419M -5.27B -402M -394M -16.95B |
| Net Debt | -379M -339M -316M -287M -540M -36.66B -544M -3.8B -1.48B -18.64B -1.42B -1.39B -59.93B | -286M -256M -238M -217M -408M -27.68B -411M -2.87B -1.12B -14.08B -1.07B -1.05B -45.25B |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | US$16.42 | -6.17% | 515,673 |
| 26-10-06 | US$17.50 | -2.75% | 521,652 |
| 26-10-05 | US$18.00 | +4.80% | 455,958 |
| 26-10-02 | US$17.17 | -3.49% | 348,657 |
| 26-10-01 | US$17.79 | +3.79% | 530,815 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
16.42USD
Average target price
42.20USD
Spread / Average Target
+157.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
